Strides And Orbicular Agree Alliance To Develop Nasal Sprays
Targeting Four Products Worth $400m In Markets Including Europe And US
Strides has agreed to partner with Orbicular to develop four nasal sprays targeting a combined market worth more than $400m for markets including Europe and the US.
